查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
体外诊断市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品和服务、技术、应用、最终用户和地理位置
市场调查报告书
商品编码
1362385

体外诊断市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品和服务、技术、应用、最终用户和地理位置

In-Vitro Diagnostic Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 订单完成后即时交付

价格

体外诊断市场预计将从2022年的723.938亿美元成长到2030年的1121.0351亿美元；预计2022年至2030年复合年增长率为5.6%。慢性病盛行率不断上升、技术进步和老年人口不断增长是推动体外诊断市场成长的值得注意因素。

体外诊断 (IVD) 是对从人体采集的血液或组织等样本进行的测试。体外诊断专门用于检测疾病或其他状况，可用于监测人的整体健康状况，以帮助治癒、治疗或预防疾病。此外，体外诊断也可用于精准医学，以确定可能受益于特定治疗或疗法的患者。因此，这些体外诊断可以包括次世代定序测试，扫描人类的 DNA 以检测基因组变异。

慢性病和传染病的盛行率不断增加

世界传染病的流行呈指数级增长。这些疾病主要是由病毒、细菌、寄生虫等病原微生物引起的。卫生条件差、缺乏公共卫生、空气污染严重以及无法获得安全饮用水等因素在加剧传染病流行方面发挥重要作用。据加拿大公共卫生局称，2020 年该国总共报告了 6,736 例丙型肝炎病例（急性、慢性和未明确的合计）。

慢性病主要包括癌症、慢性呼吸道疾病、糖尿病和心臟病。由于生物风险因素，例如酒精和烟草消费增加、不健康饮食、缺乏体力活动和肥胖流行等，这些疾病的发生率在全球范围内急剧上升。慢性病是全球死亡的主要原因。根据美国疾病管制与预防中心 (CDC) 的数据，十分之六的美国人患有至少一种慢性疾病，例如中风、癌症、心臟病或糖尿病。这些慢性疾病是美国死亡和残疾以及医疗费用迅速增长的主要原因； 2021 年，该国的医疗保健费用约为 4.1 兆美元。疾病预防控制中心的资料还表明，心臟病是男性、女性以及大多数种族和族裔群体的主要死亡原因。

根据疾病预防控制中心的资料，冠状动脉疾病（CAD）是成年人死亡的最常见原因。 2021 年，约 375,476 人死于 CAD。世界卫生组织《2022 年国家糖尿病统计报告》中发布的估计表明，全球约有 4.22 亿人患有糖尿病，其中大多数生活在低收入和中等收入国家。此外，每年有150万人死亡与糖尿病有直接关係。超重、遗传条件、老化、久坐的生活方式等正在增加糖尿病的盛行率。根据英国癌症研究中心发布的报告估计，2020 年全球新增癌症病例约为1,810 万例，预计到2040 年这一数字将增加至2,800 万例。因此，传染病和慢性病的盛行率不断上升，例如心血管疾病、癌症、糖尿病和呼吸系统疾病推动了体外诊断市场的成长。

市场趋势

对个人化医疗和基因组学的需求不断增长

北美处于个人化医疗和基因组学研究的前沿。基因组学和分子诊断越来越多地融入日常患者护理中。参与开发先进遗传学的公司在体外诊断市场上拥有大量机会。北美，特别是美国和加拿大，一直是基因组研究中心的中心，这些中心对疾病遗传基础的理解和知识、生物标誌物的识别和靶向治疗的开发做出了显着贡献。这两个国家都启动了精准医学计划，将基因组学纳入临床实践。北美一直是癌症基因组学领域的领导者，并进行了大量研究和临床试验，重点是了解与不同类型癌症相关的遗传因素。这些试验旨在评估标靶疗法、免疫疗法和其他基于患者肿瘤遗传特征的创新疗法的疗效。美国癌症协会估计，到 2023 年，美国将新增 190 万癌症病例（约每天 5,370 例），并有 609,820 人死于癌症。由于发病率如此之高，迫切需要有效的治疗来提高这些患者。

个人化医疗涉及对患者进行体外诊断测试，根据其独特特征将其分为亚组。个人化医疗领域，加上基因组定序、分子分析和其他诊断技术的进步，有可能透过提供有针对性、精确和个人化的治疗方法来彻底改变医疗保健。遗传学在全球范围内变得越来越容易获得。 2022年11月，罗氏、英国癌症研究中心和曼彻斯特大学宣布启动多药精准医学DETERMINE试验。该试验旨在评估可用的药物（包括那些被许可用于更常见癌症类型的药物）是否可以使罕见癌症类型的患者受益。该试验招募了患有罕见癌症类型的成人和儿童患者。 23and Me 和 AncestryDNA 等公司提供直接面向消费者的基因检测试剂盒，使个人能够深入了解自己的血统、遗传特征和潜在的健康风险。医疗保健提供者还提供基因检测来指导治疗决策。因此，对个人化医疗和基因组学的需求将推动预测期内体外诊断市场的成长。

「全球体外诊断市场」根据产品和服务、应用、技术、最终用户和地理位置进行细分。根据产品和服务，市场分为试剂和试剂盒、仪器、软体和服务。 2022年，试剂和试剂盒细分市场占据最大市场份额。试剂和试剂盒市场的预期成长归因于自检试剂盒和 POC 设备的巨大普及，以及简化工作并提供准确结果的自动化仪器的可用性和采用率的增加。病毒和真菌感染病例的增加以及卫生条件不足促进了试剂的使用。因此，体外诊断市场的参与者正在提供优质的分子试剂和试剂盒，以更好地管理和照顾患者。

欧洲药品管理局、紧急使用授权、疾病管制与预防中心、国际糖尿病联盟、体外诊断研究是准备体外诊断市场研究报告时参考的一些相关来源。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解
  • 体外诊断市场（按地理位置）

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：体外诊断市场格局

  • 概述
  • PEST分析
    • PEST分析

第 5 章：体外诊断市场 - 主要产业动态

  • 主要市场驱动因素
    • 慢性病和传染病的盛行率不断增加
    • COVID-19 大流行期间体外诊断需求激增
  • 市场约束
    • 监理框架和报销政策不足
  • 市场机会
    • IVD 与数位健康科技的整合
  • 未来的趋势
    • 对个人化医疗和基因组学的需求不断增长

第 6 章：体外诊断市场 - 全球市场分析

  • 体外诊断市场收入，2022 - 2030

第 7 章：全球体外诊断市场 - 收入和 2030 年预测 - 按产品和服务

  • 概述
  • 2022 年和 2030 年按产品和服务分類的体外诊断市场收入份额 (%)
  • 试剂和试剂盒
  • 软体和服务
  • 仪器

第 8 章：全球体外诊断市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年按技术分類的体外诊断市场收入份额 (%)
  • 免疫测定/免疫化学
  • 临床化学
  • 分子诊断
  • 微生物学
  • 血糖自我监测
  • 凝血与止血
  • 血液学
  • 尿液分析
  • 其他的

第 9 章：全球体外诊断市场 - 2030 年收入和预测 -按应用

  • 概述
  • 2022 年及 2030 年按应用分列的体外诊断市占率 (%)
  • 传染病
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 自体免疫疾病
  • 肾臟病学
  • 其他的

第 10 章：全球体外诊断市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年最终用户体外诊断市场收入份额 (%)
  • 医院
  • 实验室
  • 居家护理
  • 其他的

第 11 章：体外诊断市场 - 2030 年收入与预测 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：产业格局

  • 概述
  • 北美体外诊断市场的成长策略
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 13 章：公司简介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Danaher Corp
  • Siemens AG
  • Sysmex Corp
  • Thermo Fisher Scientific Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Qiagen NV

第 14 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPBT00002657

The in-vitro diagnostics market is expected to grow from US$ 72,393.80 million in 2022 to US$ 1,12,103.51 million by 2030; it is expected to grow at a CAGR of 5.6% from 2022 to 2030. The increasing prevalence of chronic diseases, technological advancements, and the growing geriatric population are the noteworthy factors driving the in-vitro diagnostics market growth.

In vitro diagnostics (IVD) are tests done on samples such as blood or tissues that have been taken from the human body. In-vitro diagnostics are specialized to detect diseases or other conditions that can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Additionally, in-vitro diagnostics may also be utilized for precision medicine to identify patients who are likely to benefit from specific treatments or therapies. Therefore, these in-vitro diagnostics can include next-generation sequencing tests that scan a person's DNA to detect genomic variations.

Increasing Prevalence of Chronic and Infectious Diseases

The world is witnessing an exponential increase in the prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Factors such as poor sanitary conditions, lack of public hygiene, elevating levels of air pollution, and unavailability of safe drinking water play a significant role in the bolstering prevalence of infectious diseases. According to the Public Health Agency of Canada, the country reported a total of 6,736 cases of hepatitis C (acute, chronic, and unspecified combined) in 2020.

Chronic diseases prominently include cancer, chronic respiratory diseases, diabetes, and heart disease. The incidences of these conditions are skyrocketing globally due to biological risk factors, such as an increase in alcohol and tobacco consumption, adoption of unhealthy diets, lack of physical activity, and prevalence of obesity. Chronic conditions are the leading cause of mortality globally. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as stroke, cancer, heart disease, or diabetes. These chronic diseases are the leading causes of death and disabilities, and burgeoning healthcare costs in the US; the country's healthcare cost was ~US$ 4.1 trillion in 2021. The CDC data also suggests that heart disease is the leading cause of death among men, women, and people of most racial and ethnic groups.

According to CDC data, coronary artery disease (CAD) is the most common cause of mortality among adults. Approximately 375,476 people died due to CAD in 2021. Estimates published in the 2022 National Diabetes Statistics Report by the World Health Organization state that ~422 million people worldwide have diabetes, the majority living in low-and middle-income countries. Moreover, 1.5 million deaths are directly related to diabetes each year. overweight, genetic conditions, aging, sedentary lifestyle, etc., are boosting the prevalence of diabetes. According to estimations published in a Cancer Research UK report, ~18.1 million new cancer cases were reported in the world in 2020, and the number is expected to increase to 28 million by 2040. Hence, the rising prevalence of infectious and chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory conditions drives the growth of the in-vitro diagnostics market.

Market Trend

Increasing Demand for Personalized Medicine and Genomics

North America is at the forefront of personalized medicine and genomics research. There is increasing integration of genomics and molecular diagnostics into routine patient care. Companies are involved in developing advanced genetics hold substantial opportunities for the in-vitro diagnostics market. North America, particularly the US and Canada, has been a hub for genomic research centers that contribute notably to understanding and knowledge on the genetic basis of diseases, identification of biomarkers, and development of targeted therapies. Both these countries have launched precision medicine initiatives to integrate genomics into clinical practices. North America has been a leader in cancer genomics, hosting extensive research and clinical trials focused on understanding the genetic factors associated with different types of cancer. These trials aim to evaluate the efficacy of targeted therapies, immunotherapies, and other innovative treatments based on the genetic characteristics of patients' tumors. The American Cancer Society estimates that the US would record 1.9 million new cancer cases (~5,370 cases per day) and 609,820 deaths from cancer in 2023. With such a high incidence, there is a pressing need for effective treatment to improve the quality of life of these patients.

Personalized medicine involves running in-vitro diagnostics tests on patients to stratify them into subgroups based on their unique characteristics. The field of personalized medicine, along with advancements in genomics sequencing, molecular profiling, and other diagnostic technologies, has the potential to revolutionize healthcare by providing targeted, precise, and individualized treatment approaches. Genetics have become increasingly accessible globally. In November 2022, Roche, Cancer Research UK, and the University of Manchester announced the launch of a multidrug, precision medicine DETERMINE trial. The trial seeks to evaluated if available agents, including those that are licensed for more common cancer types, could benefit patients with rare cancer types. The trial recruited both adult and pediatric patients with rare cancer types. Companies such as 23and Me and AncestryDNA offer direct-to-consumer genetic testing kits, allowing individuals to gain insights into their ancestry, genetic traits, and potential health risks. Healthcare providers also offer genetic testing to guide treatment decisions. Thus, the demand for personalized medicine and genomics will propel the growth of the in-vitro diagnostics market during the forecast period.

The "Global In-Vitro Diagnostic Market" is segmented on the basis of product and service, application, technology, end user, and geography. Based on product and service, the market is segmented into reagents and kits, instruments, and software and services. In 2022, the reagents and kits segment held the largest share of the market. The projected growth of the market for reagents and kits is attributed to the tremendous popularity of self-test kits and POC devices, and a rise in availability and adoption automated instruments that simplify jobs and provide accurate results. The increasing cases of viral and fungal infections with inadequate hygienic conditions promote reagent use. Thus, players in the in-vitro diagnostics market are offering superior quality molecular reagents and kits for better patient management and care.

European Medicines Agency, Emergency Use Authorization, Centers for Disease Control and Prevention, International Diabetes Federation, In-Vitro Diagnostic Research are some of the relevant sources referred while preparing the in-vitro diagnostics market research report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the in-vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global in-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 In-Vitro Diagnostics Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. In-Vitro Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 PEST Analysis

5. In-Vitro Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
    • 5.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
  • 5.2 Market Restraint
    • 5.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Integration of IVD with Digital Health Technologies
  • 5.4 Future Trends
    • 5.4.1 Increasing Demand for Personalized Medicine and Genomics

6. In-Vitro Diagnostics Market - Global Market Analysis

  • 6.1 In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 7.1 Overview
  • 7.2 In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 7.3 Reagents and Kits
    • 7.3.1 Overview
    • 7.3.2 Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Software and Services
    • 7.4.1 Overview
    • 7.4.2 Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Instruments
    • 7.5.1 Overview
    • 7.5.2 Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Immunoassay/ Immunochemistry
    • 8.3.1 Overview
    • 8.3.2 Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Chemistry
    • 8.4.1 Overview
    • 8.4.2 Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Molecular Diagnostics
    • 8.5.1 Overview
    • 8.5.2 Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Microbiology
    • 8.6.1 Overview
    • 8.6.2 Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Blood Glucose Self-Monitoring
    • 8.7.1 Overview
    • 8.7.2 Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Coagulation and Hemostasis
    • 8.8.1 Overview
    • 8.8.2 Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Hematology
    • 8.9.1 Overview
    • 8.9.2 Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Urinalysis
    • 8.10.1 Overview
    • 8.10.2 Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Others
    • 8.11.1 Overview
    • 8.11.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • 9.3 Infectious Disease
    • 9.3.1 Overview
    • 9.3.2 Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diabetes
    • 9.4.1 Overview
    • 9.4.2 Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Oncology
    • 9.5.1 Overview
    • 9.5.2 Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Cardiology
    • 9.6.1 Overview
    • 9.6.2 Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Autoimmune Diseases
    • 9.7.1 Overview
    • 9.7.2 Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.8 Nephrology
    • 9.8.1 Overview
    • 9.8.2 Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Laboratories
    • 10.4.1 Overview
    • 10.4.2 Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Homecare
    • 10.5.1 Overview
    • 10.5.2 Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 11.1 North America: In-Vitro Diagnostics Market
    • 11.1.1 Overview
    • 11.1.2 North America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.1.7 North America: In-Vitro Diagnostics Market, by Country
      • 11.1.7.1 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.1.7.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.7.1.5 US: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.1.6 US: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.1.7.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.7.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.3 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.1.7.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.7.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe: In-Vitro Diagnostics Market
    • 11.2.1 Overview
    • 11.2.2 Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.2.3 Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.2.4 Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.2.5 Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.2.6 Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.2.7 Europe: In-Vitro Diagnostics Market, by Country
      • 11.2.7.1 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.3 Germany: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.1.4 Germany: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.1.5 Germany: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.1.6 Germany: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.3 France: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.2.4 France: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.2.5 France: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.2.6 France: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.3 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.3 UK: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.3.4 UK: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.3.5 UK: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.3.6 UK: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.4 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.3 Italy: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.4.4 Italy: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.4.5 Italy: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.4.6 Italy: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.5 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.3 Spain: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.5.4 Spain: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.5.5 Spain: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.5.6 Spain: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.6 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.3 Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.6.4 Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.6.5 Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.6.6 Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific: In-Vitro Diagnostics Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.3.7 Asia Pacific: In-Vitro Diagnostics Market, by Country
      • 11.3.7.1 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.3 China: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.1.4 China: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.1.5 China: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.1.6 China: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.3 Japan: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.2.4 Japan: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.2.5 Japan: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.2.6 Japan: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.3 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.3 India: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.3.4 India: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.3.5 India: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.3.6 India: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.4 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.3 Australia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.4.4 Australia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.4.5 Australia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.4.6 Australia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.5 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.3 South Korea: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.5.4 South Korea: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.5.5 South Korea: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.5.6 South Korea: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa: In-Vitro Diagnostics Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.4.6 Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.4.7 Middle East & Africa: In-Vitro Diagnostics Market, by Country
      • 11.4.7.1 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.3 South Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.1.4 South Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.1.5 South Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.1.6 South Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.3 Saudi Arabia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.2.4 Saudi Arabia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.2.5 Saudi Arabia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.2.6 Saudi Arabia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.3 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.3 UAE: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.3.4 UAE: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.3.5 UAE: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.3.6 UAE: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.4.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.4.5 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.4.6 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America: In-Vitro Diagnostics Market
    • 11.5.1 Overview
    • 11.5.2 South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.5.3 South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.5.7 South & Central America: In-Vitro Diagnostics Market, by Country
      • 11.5.7.1 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.3 Brazil: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.5.7.1.4 Brazil: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.7.1.5 Brazil: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.1.6 Brazil: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.3 Argentina: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.5.7.2.4 Argentina: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.7.2.5 Argentina: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.2.6 Argentina: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.3 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.3 Rest of South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.5.7.3.4 Rest of South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.7.3.5 Rest of South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.3.6 Rest of South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in North America In-Vitro Diagnostics Market
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 F. Hoffmann-La Roche Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Danaher Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Siemens AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Sysmex Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Becton Dickinson and Co
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 bioMerieux SA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Bio-Rad Laboratories Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Qiagen NV
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. In-Vitro Diagnostics Market Segmentation
  • Table 2. North America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Germany In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Germany In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. France In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. France In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Italy In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Italy In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Italy In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Italy In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Spain In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Spain In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Spain In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Spain In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Rest of Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Rest of Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Rest of Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Rest of Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Asia Pacific In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Death Rate Of Cancer in 2020 Globally
  • Table 51. China In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. China In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. China In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Japan In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Japan In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Japan In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. India In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. India In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. India In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Australia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Australia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Australia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. South Korea In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. South Korea In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. South Korea In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Rest of Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Rest of Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Rest of Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Middle East & Africa In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Saudi Arabia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Saudi Arabia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Saudi Arabia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. UAE In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. UAE In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. UAE In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. UAE In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Rest of Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Brazil In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Brazil In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Brazil In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Brazil In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Argentina In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Argentina In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Argentina In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Argentina In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Organic Developments Done by Companies
  • Table 111. Inorganic Developments Done by Companies
  • Table 112. Glossary of Terms, In-Vitro Diagnostics Market

List Of Figures

  • Figure 1. In-Vitro Diagnostics Market Segmentation, By Geography
  • Figure 2. PEST Analysis
  • Figure 3. In-Vitro Diagnostics Market: Key Industry Dynamics
  • Figure 4. In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 5. In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. Global In-Vitro Diagnostics Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 8. Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 22. Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 30. Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. North America: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 35. North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. North America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 37. US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Europe: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 41. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. Europe: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 43. Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Asia Pacific: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 50. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. Asia Pacific: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 52. China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 56. South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 58. Middle East & Africa: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 59. Middle East & Africa In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 60. Middle East & Africa: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 61. South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 63. UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 64. Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 65. South & Central America: In-Vitro Diagnostics Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 66. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 67. South & Central America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 68. Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 69. Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 70. Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 71. Growth Strategies in North America In-Vitro Diagnostics Market